PenderFund Capital Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

PenderFund Capital Management’s Portfolio OMIC Stock Details OMIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,105	Closed	-$59.3K	–	175
2024 Q4	$59.3K	Buy	+2,105	New	+$39.1K	0.01%	108

PenderFund Capital Management's OMIC Position: Q1 2025 in Review

PenderFund Capital Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2025, closing a stake of 2,105 shares — an estimated $59.3K sold.

PenderFund Capital Management first reported a position in OMIC in Q4 2024 and held it in 1 quarter. The position peaked at $59.3K in Q4 2024. 0 funds tracked by Wall St. Rank hold OMIC as of Q1 2025.

PenderFund Capital Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
PenderFund Capital Management sold 2,105 Singular Genomics Systems, Inc. Common Stock shares in Q1 2025, an estimated $59.3K.
PenderFund Capital Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
PenderFund Capital Management's Singular Genomics Systems, Inc. Common Stock position peaked at $59.3K in Q4 2024.
0 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2025.

Based on PenderFund Capital Management's 13F filing for Q1 2025, filed 15 May 2025.